Nutrition therapy in peanut allergy

被引:0
|
作者
Reese I. [1 ,2 ]
Schnadt S. [1 ,2 ]
机构
[1] Ernährungsberatung und -therapie Schwerpunkt Allergologie, Ansprenger Straße 19, Munich
[2] Deutscher Allergie- und Asthmabund e. V., Mönchengladbach
关键词
Avoidance; Disease management; Education; LMIV; Risk assessment;
D O I
10.1007/s40629-021-00176-4
中图分类号
学科分类号
摘要
Background: The diagnosis “peanut allergy” is often frightening for affected persons and their families because it is perceived as life-threatening much more often than allergies to other foods. In order to be able to realistically assess risks, alleviate or dispel emerging concerns, and effectively counteract the feeling of being powerless over this diagnosis, good education, integration of affected families into existing structures, and their support in everyday life are needed. Results and discussion: Effective disease management in (peanut) allergy is based on four pillars: (a) a confirmed diagnosis, (b) knowledge about the occurrence of peanut—especially in processed form, (c) situational risk assessment as a basis for individual avoidance strategies that promise the greatest possible safety, but at the same time do not restrict the quality of life more than necessary, and (d) learning to deal adequately with unforeseen incidents (emergency management) to avoid severe allergic reactions. Conclusion: This requires close cooperation between pediatricians or allergists, allergy-experienced nutritionists or dieticians and ideally psychologists. Furthermore, the membership of a patient organization and the participation of affected persons and their environment in training measures (e.g. anaphylaxis training) is useful. © 2021, Springer Medizin Verlag GmbH, ein Teil von Springer Nature.
引用
收藏
页码:282 / 286
页数:4
相关论文
共 50 条
  • [1] White paper on peanut allergy - Part 3: Nutrition therapy in peanut allergy
    Reese, Imke
    Schnadt, Sabine
    ALLERGO JOURNAL, 2021, 30 (08) : 46 - 50
  • [2] Gene therapy for peanut allergy
    Miriam F. Moffatt
    William O.C. Cookson
    Nature Medicine, 1999, 5 : 380 - 381
  • [3] Gene therapy for peanut allergy
    Moffatt, MF
    Cookson, WOC
    NATURE MEDICINE, 1999, 5 (04) : 380 - 381
  • [4] White paper peanut allergy: Part 3: management and therapy of peanut allergy
    Blumchen K.
    Fischl A.
    Eiwegger T.
    Hamelmann E.
    Klimek L.
    Lange L.
    Szepfalusi Z.
    Vogelberg C.
    Beyer K.
    Allergo Journal International, 2022, 31 (3) : 69 - 80
  • [5] White Paper on Peanut Allergy - Part 4: Management and Therapy for Patients with Peanut Allergy
    Bluemchen, Katharina
    Fischl, Anna
    Eiwegger, Thomas
    Hamelmann, Eckard
    Klimek, Ludger
    Lange, Lars
    Szepfalusi, Zsolt
    Vogelberg, Christian
    Beyer, Kirsten
    ALLERGO JOURNAL, 2022, 31 (03) : 34 - 55
  • [6] Current Developments in the Therapy of Peanut Allergy
    Worm, Margitta
    Francuzik, Wojciech
    Dolle-Bierke, Sabine
    Lange, Lars
    Alexiou, Aikaterina
    ALLERGO JOURNAL, 2021, 30 (02) : 30 - 38
  • [7] Recent advances in the diagnosis and therapy of peanut allergy
    Sheikh, Saira Z.
    Burks, A. Wesley
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2013, 9 (06) : 551 - 560
  • [8] Peanut allergy
    Wilson, DHB
    Wilson, SM
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (03): : 302 - 302
  • [9] Peanut allergy
    de Boissieu, D
    Dupont, C
    ARCHIVES DE PEDIATRIE, 2002, 9 (07): : 739 - 743
  • [10] Allergy to peanut
    Hourihane, JO
    Warner, JO
    LANCET, 1996, 348 (9040): : 1523 - 1523